GlassScriptPhysician profile
Aimalohi Esechie
NPI 1508420738
$4,055.89
in general payments reported to CMS, 2019-2025
11 companies · $2,913 in 2025
The $2,913 reported for 2025 was more than what 78% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.89 · 2021: $15.94 · 2022: $57.42 · 2023: $245 · 2024: $809 · 2025: $2,913.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,799 · Food and Beverage: $1,168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,799.29 |
| Food and Beverage | $1,168.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $3,191.56 | 2024-2025 | Trufill, Cerenovus Enterprise, Embotrap |
| Microvention, INC. | $272.25 | 2023-2024 | Sofia 6f-131cm Str, Stent, Web Aneurysm Embolization System |
| Depuy Synthes Sales INC. | $149.34 | 2023-2025 | Trufill |
| Penumbra, INC. | $132.06 | 2025 | Penumbra System |
| Route 92 Medical, INC. | $121.63 | 2025 | |
| Abbvie INC. | $93.08 | 2022-2023 | |
| Novartis Pharmaceuticals Corporation | $34.59 | 2023 | |
| Qapel Medical INC | $16.44 | 2023 | |
| Csl Behring | $15.94 | 2021 | |
| Medtronic USA, INC. | $14.89 | 2019 | |
| Allergan, INC. | $14.11 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aimalohi Esechie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.